Skip to content
Catalyst

curcuminFinding

Curcumin decreases body mass index

lowersModerate evidenceFindingreplicated ×8

01 · The sentence it was drawn from

“The results unraveled that compared to placebo in nonalcoholic fatty liver disease, phytosomal curcumin resulted in significantly reduced BMI (MD = −0.72; 95% CI = −1.11 to −0.33; P =.0003) with significant heterogeneity among the studies (I2 = 69%, heterogeneity P =.006, Fig. 3) and body fat percent (MD = −2.04; 95% CI = −3.10 to −0.98; P =.0002) with low heterogeneity among the studies (I2 = 36%, heterogeneity P =.21, Fig. 4).”
Quoted verbatim from Influence of phytosomal curcumin on anthropometric indices for nonalcoholic fatty liver disease: A meta-analysis.
This finding among the 83 findings on its endpoint

curcumin

Body mass index

lowers

Effect as reported

−0.72mean difference

CI −1.11 to −0.33

Who
Adults with nonalcoholic fatty liver disease in randomised trials of phytosomal curcumin versus placebo; BMI pooled from 6 of 7 trials
Dose studied
phytosomal curcumin 250 to 1000 mg/day for 8 to 12 weeks across trials (one trial 800 mg), pooled

Moderate evidencePMID 39969338 · 2024

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y5Y3RVVB7HQYAMMVGKFV24